Hong Kong stock market anomalies | Kinsenry Biotechnology (01548.HK) rose over 4% in early trading, significant licensing revenue from Li Xinda landed, and Legendary Biotechnology is on the verge of turning losses around.

According to the Wise Finance and Economics APP, Kingsway Biotechnology (01548.HK) surged more than 4% in early trading, up 3.41% as of the time of publication, trading at 17.9 Hong Kong dollars, with a turnover of 2.47 billion Hong Kong dollars.